CPHA Canvax
CPHA Canvax

"The incidence of SARS-CoV-2 infection, hospitalization, and death is higher in unvaccinated than vaccinated persons, and the incidence rate ratios are related to vaccine effectiveness. Across 13 U.S. jurisdictions, incidence rate ratios for hospitalization and death changed relatively little after the SARS-CoV-2 B.1.617.2 (Delta) variant reached predominance, suggesting high, continued vaccine effectiveness against severe COVID-19. Case IRRs decreased, suggesting reduced vaccine effectiveness for prevention of SARS-CoV-2 infections. Getting vaccinated protects against severe illness from COVID-19, including the Delta variant. Monitoring COVID-19 incidence by vaccination status might provide early signals of potential changes in vaccine effectiveness that can be confirmed through robust controlled studies." - United States Centers for Disease Control and Prevention 

Additional Authors: David Blythe, Shane Brady, Betsy Cadwell, Iris Cheng, Sherri Davidson, Janelle Delgadillo, Katelynn Devinney, Jeff Duchin, Monique Duwell, Rebecca Fisher, Aaron Fleischauer, Ashley Grant, Jennifer Griffin, Meredith Haddix, Julie Hand, Matt Hanson, Eric Hawkins, Rachel K. Herlihy, Liam Hicks, Corinne Holtzman, Mikhail Hoskins, Judie Hyun, Ramandeep Kaur, Meagan Kay, Holly Kidrowski, Curi Kim, Kenneth Komatsu, Kiersten Kugeler, Melissa Lewis, B. Casey Lyons, Shelby Lyons, Ruth Lynfield, Keegan McCaffrey, Chelsea McMullen, Lauren Milroy, Stephanie Meyer, Leisha Nolen, Monita R. Patel, Sargis Pogosjans, Heather E. Reese, Amy Saupe, Jessica Sell, Theresa Sokol, Daniel Sosin, Emma Stanislawski, Kelly Stevens, Hailey Vest, Kelly White, Erica Wilson, Adam MacNeil, Matthew D. Ritchey, Benjamin J. Silk 


Related Resources





Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19,Vaccine Preventable Disease Surveillance,National Surveillance Monitoring and Surveillance
Outbreaks and Pandemics
Vaccine Preventable Disease Surveillance
National Surveillance


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.